Digest Network Come funziona
Network
/
Società
Re
Non verificato

Revelation Biosciences, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

23 comunicati stampa

Guarda tutti i comunicati
08/08/2025
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Mercato azionario
Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2025
Fonte
Revelation Biosciences, Inc.
Emittente
Business Wire
1.00
0
24/07/2025
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Medicina - Varie
Mercato del lavoro
Revelation Biosciences, Inc. Congratulates Its Former Chairman of the Board, George Tidmarsh, on His Appointment as the Head of the FDA Center for Drug Evaluation and Research
Fonte
Revelation Biosciences, Inc.
Emittente
Business Wire
1.00
0
16/07/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Industria
Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study
Fonte
Revelation Biosciences, Inc.
Emittente
Business Wire
1.00
0
01/07/2025
Biotecnologia
HIV, AIDS e malattie autoimmuni
Salute
Farmaceutica
Medicina - Varie
Finanza
Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025
Fonte
Revelation Biosciences, Inc.
Emittente
Business Wire
1.00
0
29/05/2025
Biotecnologia
HIV, AIDS e malattie autoimmuni
Salute
Farmaceutica
Medicina - Varie
Mercato azionario
Finanza
Revelation Biosciences, Inc. Announces Closing of $4 Million Public Offering
Fonte
Revelation Biosciences, Inc.
Emittente
Business Wire
1.00
0
29/05/2025
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Finanza
Revelation Biosciences, Inc. Announces Pricing of $4 Million Public Offering
Fonte
Revelation Biosciences, Inc.
Emittente
Business Wire
1.00
0
23/05/2025
Mercato del lavoro
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Revelation Biosciences Announces Retirement of George Tidmarsh, MD, PhD from Board of Directors
Fonte
Revelation Biosciences, Inc.
Emittente
Business Wire
1.00
0
08/05/2025
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025
Fonte
Revelation Biosciences, Inc.
Emittente
Business Wire
1.00
0
29/04/2025
Industria
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Revelation Biosciences to Develop Gemini for Infection in Severe Burn Patients
Fonte
Revelation Biosciences, Inc.
Emittente
Business Wire
1.00
0
17/03/2025
Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells
Fonte
Revelation Biosciences, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0